Natan R Kahan

Summary

Affiliation: The Hebrew University
Country: Israel

Publications

  1. ncbi Drug use evaluation of tamoxifen focusing on off-label use in a managed care population in Israel
    Natan R Kahan
    Leumit Health Fund, POB 20083, Tel Aviv, 64738, Israel
    J Manag Care Pharm 16:355-9. 2010
  2. ncbi Curtailing laboratory test ordering in a managed care setting through redesign of a computerized order form
    Natan R Kahan
    Leumit Health Fund, PO Box 20083, Tel Aviv, 64738 Israel
    Am J Manag Care 15:173-6. 2009
  3. ncbi The tools of an evidence-based culture: implementing clinical-practice guidelines in an Israeli HMO
    Natan R Kahan
    Medical Division, Leumit Health Fund, Tel Aviv, Israel
    Acad Med 84:1217-25. 2009
  4. ncbi When gatekeepers meet the sentinel: the impact of a prior authorization requirement for cefuroxime on the prescribing behaviour of community-based physicians
    Natan R Kahan
    Leumit Health Fund, Tel Aviv, Israel
    Br J Clin Pharmacol 61:341-4. 2006
  5. ncbi Economic evaluation of an updated guideline for the empiric treatment of uncomplicated urinary tract infection in women
    Natan R Kahan
    Leumit Health Fund, Tel Aviv, Israel
    Isr Med Assoc J 6:588-91. 2004
  6. ncbi Suboptimal pneumococcal pneumonia vaccination rates among patients at risk in a managed care organization in Israel
    Natan R Kahan
    Leumit Health Fund, 23 Schprintsak St, Tel Aviv 64738, Israel
    J Manag Care Pharm 12:152-7. 2006
  7. ncbi Physician adherence to recommendations for duration of empiric antibiotic treatment for uncomplicated urinary tract infection in women: a national drug utilization analysis
    Natan R Kahan
    Leumit Health Fund, Tel Aviv, Israel
    Pharmacoepidemiol Drug Saf 13:239-42. 2004
  8. ncbi A pharmacoepidemiological approach to investigating inappropriate physician prescribing in a managed care setting in Israel
    Natan R Kahan
    Leumit Health Fund, Tel Aviv, Israel corrected
    Am J Manag Care 11:89-90. 2005
  9. ncbi Teaching evidence-based medicine in a managed care setting: from didactic exercise to pharmacopolicy development tool
    Natan R Kahan
    Leumit Health Fund, Tel Aviv, Israel
    Am J Manag Care 11:570-2. 2005
  10. ncbi Modifying prescribing behaviour of angiotensin receptor blockers by selectively rescinding managerial prior authorization requirements for losartan
    Natan R Kahan
    The Center for the Study of Rationality, The Hebrew University of Jerusalem, Jerusalem, Israel
    Br J Clin Pharmacol 72:997-1001. 2011

Collaborators

Detail Information

Publications12

  1. ncbi Drug use evaluation of tamoxifen focusing on off-label use in a managed care population in Israel
    Natan R Kahan
    Leumit Health Fund, POB 20083, Tel Aviv, 64738, Israel
    J Manag Care Pharm 16:355-9. 2010
    ..This DUE was motivated by observations that tamoxifen may be used off-label for indications without evidence of safety or efficacy...
  2. ncbi Curtailing laboratory test ordering in a managed care setting through redesign of a computerized order form
    Natan R Kahan
    Leumit Health Fund, PO Box 20083, Tel Aviv, 64738 Israel
    Am J Manag Care 15:173-6. 2009
    ..To increase appropriate use of blood tests for folic acid and vitamin B12 ordered by primary care physicians in a managed care organization in Israel through redesign of a computerized order form...
  3. ncbi The tools of an evidence-based culture: implementing clinical-practice guidelines in an Israeli HMO
    Natan R Kahan
    Medical Division, Leumit Health Fund, Tel Aviv, Israel
    Acad Med 84:1217-25. 2009
    ..The purpose of this study was to design and implement an effective program for formulating, promulgating, and implementing CPGs to foster the development of an evidence-based culture in an Israeli HMO...
  4. ncbi When gatekeepers meet the sentinel: the impact of a prior authorization requirement for cefuroxime on the prescribing behaviour of community-based physicians
    Natan R Kahan
    Leumit Health Fund, Tel Aviv, Israel
    Br J Clin Pharmacol 61:341-4. 2006
    ..The purpose of this study was to assess the affect a PA restriction had on the utilization patterns of cefuroxime tablets in a managed care organization (MCO) in Israel...
  5. ncbi Economic evaluation of an updated guideline for the empiric treatment of uncomplicated urinary tract infection in women
    Natan R Kahan
    Leumit Health Fund, Tel Aviv, Israel
    Isr Med Assoc J 6:588-91. 2004
    ..However, due to increased uropathogen resistance to this drug, the fund has designated nitrofurantoin as its new drug of choice...
  6. ncbi Suboptimal pneumococcal pneumonia vaccination rates among patients at risk in a managed care organization in Israel
    Natan R Kahan
    Leumit Health Fund, 23 Schprintsak St, Tel Aviv 64738, Israel
    J Manag Care Pharm 12:152-7. 2006
    ..The purpose of this study was to (a) evaluate the vaccination rates among high-risk patients in a managed care setting in Israel and (b) gain a better understanding of the factors associated with suboptimal use of this vaccine...
  7. ncbi Physician adherence to recommendations for duration of empiric antibiotic treatment for uncomplicated urinary tract infection in women: a national drug utilization analysis
    Natan R Kahan
    Leumit Health Fund, Tel Aviv, Israel
    Pharmacoepidemiol Drug Saf 13:239-42. 2004
    ..Since this issue is of global importance, we believe our evaluation can serve as model for other settings and countries...
  8. ncbi A pharmacoepidemiological approach to investigating inappropriate physician prescribing in a managed care setting in Israel
    Natan R Kahan
    Leumit Health Fund, Tel Aviv, Israel corrected
    Am J Manag Care 11:89-90. 2005
    ..To identify cases of inappropriate physician prescribing in a managed care setting in Israel that may have resulted from misuse of magnetic-stripe membership cards...
  9. ncbi Teaching evidence-based medicine in a managed care setting: from didactic exercise to pharmacopolicy development tool
    Natan R Kahan
    Leumit Health Fund, Tel Aviv, Israel
    Am J Manag Care 11:570-2. 2005
    ..To implement a residency-based program for the teaching of evidence-based medicine in an Israeli HMO and to incorporate this effort into the HMO's routine drug policy formulation process...
  10. ncbi Modifying prescribing behaviour of angiotensin receptor blockers by selectively rescinding managerial prior authorization requirements for losartan
    Natan R Kahan
    The Center for the Study of Rationality, The Hebrew University of Jerusalem, Jerusalem, Israel
    Br J Clin Pharmacol 72:997-1001. 2011
    ..To evaluate whether rescinding the prior authorization (PA) requirement (managerial pre-approval) for losartan in an health maintenance organization (HMO) could reduce prescribing of the more expensive angiotensin receptor blockers (ARBs)...
  11. ncbi Prior authorization to improve testing of glycosylated hemoglobin in a managed care setting
    Natan R Kahan
    Medical Division, Leumit Health Fund, PO Box 20083, Tel Aviv 64738, Israel
    Am J Manag Care 15:582-4. 2009
    ..To ascertain whether revocation of a prior authorization (PA) requirement by the Leumit Health Fund of Israel resulted in inferior rates of glycosylated hemoglobin (A1C) testing among new users of expensive diabetes medications...
  12. ncbi Urinary tract infection in women--physician's preferences for treatment and adherence to guidelines: a national drug utilization study in a managed care setting
    Ernesto Kahan
    Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Eur J Clin Pharmacol 59:663-8. 2003
    ..Trimethoprim-sulfamethoxazole (TMP-SMX) and nitrofurantoin are the two drugs currently recommended in clinical guidelines in Israel for uncomplicated UTI in women...